End-of-day quote
Shenzhen S.E.
06:00:00 2024-07-04 pm EDT
|
5-day change
|
1st Jan Change
|
11.28
CNY
|
+8.46%
|
|
+12.13%
|
-20.56%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
24,714
|
45,574
|
44,945
|
37,519
|
23,854
|
18,893
|
-
|
-
|
Enterprise Value (EV)
1 |
24,400
|
45,291
|
43,965
|
36,049
|
22,526
|
17,160
|
16,757
|
16,287
|
P/E ratio
|
52
x
|
79.4
x
|
60.4
x
|
41.3
x
|
25.9
x
|
19
x
|
15.8
x
|
14.1
x
|
Yield
|
0.23%
|
0.13%
|
0.22%
|
0.27%
|
0.7%
|
0.86%
|
1.03%
|
1.22%
|
Capitalization / Revenue
|
7.76
x
|
12.8
x
|
10.4
x
|
7.31
x
|
4.26
x
|
3
x
|
2.58
x
|
2.26
x
|
EV / Revenue
|
7.66
x
|
12.7
x
|
10.2
x
|
7.03
x
|
4.02
x
|
2.73
x
|
2.29
x
|
1.95
x
|
EV / EBITDA
|
29.5
x
|
46.5
x
|
36.6
x
|
26
x
|
16.4
x
|
10.8
x
|
9.12
x
|
7.89
x
|
EV / FCF
|
69.5
x
|
117
x
|
85.9
x
|
78.4
x
|
47.9
x
|
25.9
x
|
30.2
x
|
23.7
x
|
FCF Yield
|
1.44%
|
0.85%
|
1.16%
|
1.28%
|
2.09%
|
3.86%
|
3.31%
|
4.22%
|
Price to Book
|
7.85
x
|
12.2
x
|
10.1
x
|
6.86
x
|
3.85
x
|
2.68
x
|
2.34
x
|
2.07
x
|
Nbr of stocks (in thousands)
|
1,657,531
|
1,665,091
|
1,672,688
|
1,682,458
|
1,679,828
|
1,674,927
|
-
|
-
|
Reference price
2 |
14.91
|
27.37
|
26.87
|
22.30
|
14.20
|
11.28
|
11.28
|
11.28
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/25/22
|
2/27/23
|
4/18/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,183
|
3,568
|
4,329
|
5,131
|
5,605
|
6,297
|
7,318
|
8,351
|
EBITDA
1 |
828.5
|
973.3
|
1,200
|
1,384
|
1,375
|
1,592
|
1,836
|
2,064
|
EBIT
1 |
522.1
|
652.1
|
850.2
|
1,022
|
1,007
|
1,084
|
1,309
|
1,474
|
Operating Margin
|
16.4%
|
18.28%
|
19.64%
|
19.93%
|
17.98%
|
17.21%
|
17.88%
|
17.65%
|
Earnings before Tax (EBT)
1 |
536.2
|
651.3
|
849.5
|
1,024
|
1,011
|
1,111
|
1,345
|
1,507
|
Net income
1 |
476.4
|
577.6
|
746.2
|
902.7
|
910.2
|
997.7
|
1,199
|
1,346
|
Net margin
|
14.97%
|
16.19%
|
17.24%
|
17.59%
|
16.24%
|
15.84%
|
16.38%
|
16.11%
|
EPS
2 |
0.2865
|
0.3449
|
0.4446
|
0.5403
|
0.5474
|
0.5930
|
0.7131
|
0.8008
|
Free Cash Flow
1 |
351
|
385.6
|
512
|
459.8
|
470.7
|
661.8
|
555.3
|
686.7
|
FCF margin
|
11.03%
|
10.81%
|
11.83%
|
8.96%
|
8.4%
|
10.51%
|
7.59%
|
8.22%
|
FCF Conversion (EBITDA)
|
42.37%
|
39.62%
|
42.65%
|
33.22%
|
34.23%
|
41.58%
|
30.24%
|
33.27%
|
FCF Conversion (Net income)
|
73.68%
|
66.76%
|
68.62%
|
50.94%
|
51.71%
|
66.33%
|
46.33%
|
51.04%
|
Dividend per Share
2 |
0.0350
|
0.0350
|
0.0600
|
0.0600
|
0.1000
|
0.0976
|
0.1157
|
0.1372
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/25/22
|
2/27/23
|
4/18/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2021 S1
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
1,809
|
1,319
|
907.7
|
1,264
|
1,443
|
1,516
|
1,117
|
1,439
|
1,525
|
1,523
|
1,192
|
1,603
|
1,737
|
1,781
|
1,348
|
1,848
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
289.7
|
449.1
|
476.9
|
180.8
|
268.7
|
477.4
|
519
|
278
|
286.2
|
532.3
|
EBIT
1 |
-
|
341
|
216.9
|
134.7
|
277.6
|
343.1
|
267
|
169.2
|
321.9
|
349.2
|
167.2
|
139.6
|
324.1
|
368.3
|
153.1
|
152.9
|
399.1
|
Operating Margin
|
-
|
18.86%
|
16.45%
|
14.84%
|
21.96%
|
23.78%
|
17.61%
|
15.14%
|
22.37%
|
22.89%
|
10.98%
|
11.72%
|
20.22%
|
21.2%
|
8.59%
|
11.34%
|
21.59%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
192.3
|
301.2
|
-
|
-
|
-
|
-
|
239.4
|
144.3
|
283.9
|
312.7
|
169.4
|
132.5
|
316.9
|
347.8
|
230.5
|
141
|
362.1
|
Net margin
|
-
|
16.66%
|
-
|
-
|
-
|
-
|
15.79%
|
12.91%
|
19.73%
|
20.5%
|
11.12%
|
11.12%
|
19.77%
|
20.02%
|
12.94%
|
10.46%
|
19.59%
|
EPS
2 |
0.1154
|
-
|
0.1100
|
0.0714
|
0.1400
|
0.1900
|
0.1449
|
0.0862
|
0.1600
|
0.1900
|
0.1100
|
0.0791
|
0.1694
|
0.1956
|
0.1323
|
0.0838
|
0.2152
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
0.0600
|
-
|
-
|
-
|
0.1000
|
-
|
-
|
-
|
0.0993
|
-
|
-
|
Announcement Date
|
8/24/20
|
8/24/21
|
2/25/22
|
4/24/22
|
8/24/22
|
10/25/22
|
2/27/23
|
4/24/23
|
8/10/23
|
10/24/23
|
4/18/24
|
4/18/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
314
|
283
|
980
|
1,470
|
1,328
|
1,734
|
2,136
|
2,606
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
351
|
386
|
512
|
460
|
471
|
662
|
555
|
687
|
ROE (net income / shareholders' equity)
|
16.3%
|
16.8%
|
18.2%
|
18.2%
|
15.6%
|
14.5%
|
15.2%
|
15.1%
|
ROA (Net income/ Total Assets)
|
11.2%
|
11.7%
|
12.5%
|
12.6%
|
11%
|
10.2%
|
10.6%
|
11%
|
Assets
1 |
4,247
|
4,944
|
5,962
|
7,160
|
8,291
|
9,798
|
11,292
|
12,265
|
Book Value Per Share
2 |
1.900
|
2.250
|
2.660
|
3.250
|
3.690
|
4.200
|
4.820
|
5.450
|
Cash Flow per Share
2 |
0.4800
|
0.5600
|
0.6400
|
0.6500
|
0.6700
|
0.8700
|
1.010
|
1.050
|
Capex
1 |
444
|
545
|
561
|
641
|
652
|
704
|
696
|
826
|
Capex / Sales
|
13.95%
|
15.29%
|
12.95%
|
12.49%
|
11.63%
|
11.18%
|
9.51%
|
9.9%
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/25/22
|
2/27/23
|
4/18/24
|
-
|
-
|
-
|
Last Close Price
11.28
CNY Average target price
15.86
CNY Spread / Average Target +40.63% Consensus |
1st Jan change
|
Capi.
|
---|
| -20.56% | 2.6B | | +11.22% | 17.02B | | 0.00% | 8.42B | | -26.11% | 2.25B | | -26.80% | 1.85B | | +14.78% | 951M | | -20.85% | 940M | | -18.23% | 934M | | -2.28% | 739M | | -31.19% | 639M |
Testing Laboratories
|